Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals

BACKGROUND: Booster vaccine doses against SARS-CoV-2 have been advocated to address evidence of waning immunity, breakthrough infection, and the emergence of immune-evasive variants. A heterologous prime-boost vaccine strategy may offer advantages over a homologous approach, but the safety and effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallah, Saad I., Alawadhi, Abdulla, Jawad, Jaleela, Wasif, Pearl, Alsaffar, Basma, Alalawi, Ejlal, Mohamed, Afaf Merza, Butler, Alexandra E., Alalawi, Batool, Qayed, Donia, Almahari, Sayed Ali, Mubarak, Ali, Mubarak, Aalaa, Saeed, Sawsan, Humaidan, Ahmed, Kumar, Nitya, Atkin, Stephen, Alqahtani, Manaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868355/
https://www.ncbi.nlm.nih.gov/pubmed/36725431
http://dx.doi.org/10.1016/j.vaccine.2023.01.032

Ejemplares similares

Ejemplares similares